Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman’s formula in subjects with epidermal melasma: A randomized, double‐blind clinical trial study

黄褐斑 半胱胺 医学 耐受性 皮肤病科 临床试验 随机对照试验 不利影响 内科学
作者
Maryam Karrabi,Jennifer David,Mohammad Sahebkar
出处
期刊:Skin Research and Technology [Wiley]
卷期号:27 (1): 24-31 被引量:41
标识
DOI:10.1111/srt.12901
摘要

Abstract Background Kligman’s formula (KF) remains to date the dermatologists’ treatment of choice for melasma. This study was aimed at the evaluation of the effectiveness of Modified Kligman’s formula (MKF) in comparison with cysteamine 5% cream on the severity of epidermal melasma. Materials and Methods A total of 50 subjects with epidermal melasma were included in this double‐blind, randomized trial study. Subjects received either cysteamine 5% cream or an MKF (4% hydroquinone, 0.05% retinoic acid and 0.1% betamethasone). Cysteamine cream (applied once daily, 15 minutes exposure) or MKF (applied once daily, whole night exposure) were used by the subjects over four consecutive months. The efficacy of the treatments was determined through the modified Melasma Area Severity Index (mMASI) score, the Investigator’s Global Assessment (IGA) and patient questionnaires. Results The mean (SD) age of the subjects was 34.96 (6.17) and 35.76 (5.23) years for cysteamine and MKF group, respectively. The mean mMASI score after 4 months was 7.04 (2.23) in the MKF group and 6.09 (2.01) in the cysteamine group. At both prospective evaluation points (2 months, 4 months), the percentage reduction in mMASI score was approximately 9% greater by cysteamine cream as compared to MKF, and these differences were statistically significant ( P = .005 and .001 respectively). Conclusion Cysteamine 5% cream showed greater efficacy as compared to MKF. It is thus proposed that cysteamine 5% cream is more effective than MKF in the treatment of melasma, with the advantage of being significantly better tolerated.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
叉叉发布了新的文献求助10
刚刚
Megan发布了新的文献求助10
刚刚
ljh完成签到,获得积分10
刚刚
苦行僧完成签到,获得积分10
1秒前
CAOHOU的应助被如懿采纳,获得10
1秒前
1秒前
1秒前
proudzhu完成签到,获得积分10
2秒前
Tycoon完成签到,获得积分10
2秒前
2秒前
木子完成签到,获得积分10
3秒前
zyy发布了新的文献求助10
3秒前
4秒前
落后千雁完成签到,获得积分10
4秒前
西瓜瓜发布了新的文献求助20
4秒前
fake发布了新的文献求助10
6秒前
大萌完成签到,获得积分10
6秒前
MEOW完成签到,获得积分10
6秒前
Tycoon发布了新的文献求助10
7秒前
可爱的函函的应助被快乐的鱼采纳,获得10
7秒前
木光完成签到,获得积分10
7秒前
7秒前
nnn发布了新的文献求助30
7秒前
orixero的应助被等闲采纳,获得30
8秒前
8秒前
张豪博完成签到,获得积分10
8秒前
hanyouyou完成签到 ,获得积分10
8秒前
xxx完成签到,获得积分10
9秒前
9秒前
踏实发夹完成签到,获得积分10
10秒前
白菜完成签到,获得积分10
11秒前
魅力小鼠完成签到,获得积分10
11秒前
chenaideyu完成签到,获得积分10
12秒前
zyy发布了新的文献求助10
12秒前
Duang发布了新的文献求助10
12秒前
ee完成签到,获得积分10
12秒前
大军门诊完成签到,获得积分10
13秒前
xxx发布了新的文献求助10
13秒前
李爱国的应助被XH采纳,获得10
14秒前
酷波er的应助被Megan采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181949
求助须知:如何正确求助?哪些是违规求助? 9571702
关于积分的说明 21819272
捐赠科研通 7778399
什么是DOI,文献DOI怎么找? 3433572
关于科研通互助平台的介绍 2557769
邀请新用户注册赠送积分活动 2479630